185 related articles for article (PubMed ID: 21746943)
1. In vitro antibacterial activity of NB-003 against Propionibacterium acnes.
Pannu J; McCarthy A; Martin A; Hamouda T; Ciotti S; Ma L; Sutcliffe J; Baker JR
Antimicrob Agents Chemother; 2011 Sep; 55(9):4211-7. PubMed ID: 21746943
[TBL] [Abstract][Full Text] [Related]
2. In vitro antimicrobial activity of benzoyl peroxide against Propionibacterium acnes assessed by a novel susceptibility testing method.
Okamoto K; Ikeda F; Kanayama S; Nakajima A; Matsumoto T; Ishii R; Umehara M; Gotoh N; Hayashi N; Iyoda T; Matsuzaki K; Matsumoto S; Kawashima M
J Infect Chemother; 2016 Jun; 22(6):426-9. PubMed ID: 26806150
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains.
Gloor M; Wasik B; Becker A; Höffler U
Dermatology; 2002; 205(3):260-4. PubMed ID: 12399674
[TBL] [Abstract][Full Text] [Related]
4. Effects of subminimal inhibitory concentrations of erythromycin, tetracycline, clindamycin, and minocycline on the neutrophil chemotactic factor production in Propionibacterium acnes biotypes 1-5.
Akamatsu H; Nishijima S; Takahashi M; Ushijima T; Asada Y
J Dermatol; 1991 May; 18(5):247-51. PubMed ID: 1834712
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of kaempferol isolated from the Impatiens balsamina alone and in combination with erythromycin or clindamycin against Propionibacterium acnes.
Lim YH; Kim IH; Seo JJ
J Microbiol; 2007 Oct; 45(5):473-7. PubMed ID: 17978809
[TBL] [Abstract][Full Text] [Related]
6. In vivo antibacterial effects of tretinoin-clindamycin and clindamycin alone on Propionibacterium acnes with varying clindamycin minimum inhibitory.
Leyden JJ
J Drugs Dermatol; 2012 Dec; 11(12):1434-8. PubMed ID: 23377513
[TBL] [Abstract][Full Text] [Related]
7. [Fundamental studies on antibacterial activity of clindamycin against Propionibacterium acnes].
Komagata Y; Komiyama K; Nomura S
Jpn J Antibiot; 1998 Feb; 51(2):130-6. PubMed ID: 9575439
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal activity and post-antibiotic effect of ozenoxacin against Propionibacterium acnes.
Kanayama S; Okamoto K; Ikeda F; Ishii R; Matsumoto T; Hayashi N; Gotoh N
J Infect Chemother; 2017 Jun; 23(6):374-380. PubMed ID: 28389164
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne.
Schafer F; Fich F; Lam M; Gárate C; Wozniak A; Garcia P
Int J Dermatol; 2013 Apr; 52(4):418-25. PubMed ID: 23432195
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic-resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%.
Leyden JJ; Wortzman M; Baldwin EK
Cutis; 2008 Dec; 82(6):417-21. PubMed ID: 19181031
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia.
Ross JI; Snelling AM; Eady EA; Cove JH; Cunliffe WJ; Leyden JJ; Collignon P; Dréno B; Reynaud A; Fluhr J; Oshima S
Br J Dermatol; 2001 Feb; 144(2):339-46. PubMed ID: 11251569
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic sensitivity of comedonal Propionibacterium acnes.
Guin JD; Huber DS; Gielerak PL
Acta Derm Venereol; 1979; 59(6):552-54. PubMed ID: 94223
[TBL] [Abstract][Full Text] [Related]
13. Resistance of propionibacteria to antibiotics used in the treatment of acne.
Brown JM; Poston SM
J Med Microbiol; 1983 Aug; 16(3):271-80. PubMed ID: 6224016
[TBL] [Abstract][Full Text] [Related]
14. The combination formulation of clindamycin 1% plus benzoyl peroxide 5% versus 3 different formulations of topical clindamycin alone in the reduction of Propionibacterium acnes. An in vivo comparative study.
Leyden J; Kaidbey K; Levy SF
Am J Clin Dermatol; 2001; 2(4):263-6. PubMed ID: 11705253
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
[TBL] [Abstract][Full Text] [Related]
16. Effect of clindamycin, erythromycin, lincomycin, and tetracycline on growth and extracellular lipase production by propionibacteria in vitro.
Unkles SE; Gemmell CG
Antimicrob Agents Chemother; 1982 Jan; 21(1):39-43. PubMed ID: 7081974
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong.
Luk NM; Hui M; Lee HC; Fu LH; Liu ZH; Lam LY; Eastel M; Chan YK; Tang LS; Cheng TS; Siu FY; Ng SC; Lai YK; Ho KM
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):31-6. PubMed ID: 22103749
[TBL] [Abstract][Full Text] [Related]
18. A Myrtus communis extract enriched in myrtucummulones and ursolic acid reduces resistance of Propionibacterium acnes biofilms to antibiotics used in acne vulgaris.
Feuillolay C; Pecastaings S; Le Gac C; Fiorini-Puybaret C; Luc J; Joulia P; Roques C
Phytomedicine; 2016 Mar; 23(3):307-15. PubMed ID: 26969384
[TBL] [Abstract][Full Text] [Related]
19. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.
Nishijima S; Kurokawa I; Katoh N; Watanabe K
J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198
[TBL] [Abstract][Full Text] [Related]
20. The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne.
Nishijima S; Akamatsu H; Akamatsu M; Kurokawa I; Asada Y
J Dermatol; 1994 Mar; 21(3):166-71. PubMed ID: 8014270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]